Jubilant Life Sciences receives ANDA approval for Olmesartan Medoxomil tablets

http://ift.tt/2nvNmgn
Jubilant Life Sciences has received Abbreviated New Drug Application final approval for Olmesartan Medoxomil tablets, 5mg, 20 mg and 40 mg, the generic version of Benicar of Daiichi Sankyo, which is used for treatment of hypertension.

April 25, 2017 at 10:35AM

http://ift.tt/2oGraNp

from

http://ift.tt/2oGraNp